MedTrace Logo

Clonal Hematopoiesis of Immunological Significance

NCT05969821 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2026-03-23

No results posted yet for this study

Summary

Ambispective, national, multicenter observational cohort study aimed at characterizing the satellite dysimmune manifestations of clonal hematopoiesis, including Vexas (Vacuoles, E1 enzyme, X-linked, Autoinflammatory and Somatic) syndrome.

Conditions

Interventions

OTHER

observational cohort study

observational cohort study

Sponsors & Collaborators

  • Sorbonne University

    collaborator OTHER

  • Institut National de la Santé Et de la Recherche Médicale, France

    collaborator OTHER_GOV

  • Club MINHEMON (MEDECINE INTERNE, HEMATO ET ONCO)

    collaborator UNKNOWN

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Arsene MEKINIAN, MD PhD · Service de médecine interne, Hôpital Saint Antoine, APHP, Paris

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-30
Primary Completion
2036-04-30
Completion
2045-09-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05969821 on ClinicalTrials.gov